JESSE I TREU Insider Trading $CLVS Clovis Oncology, Inc.
Get free email notifications about insider trading for JESSE I TREU.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JESSE I TREU. JESSE I TREU is 10% Owner in SENOMYX INC ($SNMX) and 10% Owner in INTRALASE CORP ($ILSE) and 10% Owner in Paratek Pharmaceuticals, Inc. ($PRTK) and 10% Owner in SANTARUS INC ($SNTS) and 10% Owner in NUVASIVE INC ($NUVA) and 10% Owner in ALIMERA SCIENCES INC ($ALIM) and 10% Owner in Ocera Therapeutics, Inc. ($TZYM) and Director in Northstar Neuroscience, Inc. ($NSTR) and 10% Owner in ACHILLION PHARMACEUTICALS INC ($ACHN) and 10% Owner in Achaogen Inc ($AKAO) and Director in Tobira Therapeutics, Inc. ($TBRA) and 10% Owner in CADENCE PHARMACEUTICALS INC ($CADX) and Director in SENORX INC ($SENO) and Director in Pernix Sleep, Inc. ($SOMX) and Director in CoLucid Pharmaceuticals, Inc. ($CLCD) and 10% Owner in INTERCELL USA, INC. ($IOMI) and Director in Aldeyra Therapeutics, Inc. ($ALDX) and 10% Owner in Vanda Pharmaceuticals Inc. ($VNDA) and 10% Owner in Volcano Corp ($VOLC) and 10% Owner in ZOGENIX, INC. ($ZGNX) and Director in VERACYTE, INC. ($VCYT) and 10% Owner in Orexigen Therapeutics, Inc. ($OREX) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and 10% Owner in Evoke Pharma Inc ($EVOK) and 10% Owner in Esperion Therapeutics, Inc. ($ESPR) and Director in TANDEM DIABETES CARE INC ($TNDM) and 10% Owner in Clovis Oncology, Inc. ($CLVS) and 10% Owner in REVA Medical, Inc. ($RVA) and 10% Owner in Durata Therapeutics, Inc. ($DRTX).
JESSE I TREU in Clovis Oncology, Inc.
Trading Symbol: CLVSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JESSE I TREU: 10% Owner
Holdings: 51,013 shares
Current Value: $3,060,780
Latest Transaction: Nov 21 2011
$CLVS Market Capitalization: $2.45B
$CLVS Previous Close: $60.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JESSE I TREU in Clovis Oncology, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKAO, ACHN, ALDX, ALIM, CADX, CLVS, CLCD, DRNA, DRTX, ESPR, EVOK, IOMI, ILSE, NSTR, NUVA, TZYM, OREX, PRTK, SOMX, RVA, SNTS, SNMX, SENO, TNDM, TBRA, VNDA, VCYT, VOLC, ZGNX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 21 2011 | CLVS | Clovis Oncology, I ... | TREU JESSE I | 10% Owner | Option Exercise | C | 0.00 | 43,809 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | TREU JESSE I | 10% Owner | Option Exercise | C | 0.00 | 20,240 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | TREU JESSE I | 10% Owner | Option Exercise | C | 0.00 | 20,240 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | TREU JESSE I | 10% Owner | Option Exercise | C | 0.00 | 2,568,521 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | TREU JESSE I | 10% Owner | Option Exercise | C | 0.00 | 1,186,657 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | TREU JESSE I | 10% Owner | Option Exercise | C | 0.00 | 1,186,657 | 0 | 0 | |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | TREU JESSE I | 10% Owner | Buy | P | 13.00 | 15,625 | 203,125 | 51,013 | 35.4 K to 51 K (+44.15 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | TREU JESSE I | 10% Owner | Buy | C | 0.00 | 6,324 | 0 | 35,388 | 29.1 K to 35.4 K (+21.76 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | TREU JESSE I | 10% Owner | Buy | C | 0.00 | 15,106 | 0 | 29,064 | 14 K to 29.1 K (+108.22 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | TREU JESSE I | 10% Owner | Buy | C | 0.00 | 6,979 | 0 | 13,958 | 7 K to 14 K (+100.00 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | TREU JESSE I | 10% Owner | Buy | C | 0.00 | 6,979 | 0 | 6,979 | 0 to 7 K |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | TREU JESSE I | 10% Owner | Buy | P | 13.00 | 916,058 | 11,908,754 | 2,990,937 | 2.1 M to 3 M (+44.15 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | TREU JESSE I | 10% Owner | Buy | C | 0.00 | 370,799 | 0 | 2,074,879 | 1.7 M to 2.1 M (+21.76 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | TREU JESSE I | 10% Owner | Buy | C | 0.00 | 885,696 | 0 | 1,704,080 | 818.4 K to 1.7 M (+108.22 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | TREU JESSE I | 10% Owner | Buy | C | 0.00 | 409,192 | 0 | 818,384 | 409.2 K to 818.4 K (+100.00 %) |
Nov 21 2011 | CLVS | Clovis Oncology, I ... | TREU JESSE I | 10% Owner | Buy | C | 0.00 | 409,192 | 0 | 409,192 | 0 to 409.2 K |
Page: 1